Aziyo Biologics Provides Business Update and Preliminary Third Quarter 2021 Revenue Results and Announces Timing for Third Quarter 2021 Financial Results
October 25, 2021 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference
September 15, 2021 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics Appoints Peter G. Edwards as General Counsel
August 31, 2021 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Reports Second Quarter 2021 Financial Results
August 09, 2021 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021
July 26, 2021 16:01 ET
|
Aziyo Biologics
SILVER SPRING, Md., July 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix
June 07, 2021 08:00 ET
|
Aziyo Biologics
SILVER SPRING, Md., June 07, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) on June 2, 2021 issued a voluntary recall pertaining to a single donor lot of its FiberCel Fiber Viable...
Aziyo Biologics Reports First Quarter 2021 Financial Results and Increases 2021 Revenue Guidance
May 04, 2021 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., May 04, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated...
Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study
April 28, 2021 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 28, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit
April 26, 2021 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...
Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
April 20, 2021 16:05 ET
|
Aziyo Biologics
SILVER SPRING, Md., April 20, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of...